Clinical Trials in Chicago

Showing 4161-4180 of 20,493 trials

ED Physical Therapy for Chronic Low Back Pain

NCT05206630

Emergency department (ED)-initiated physical therapy is a rapidly growing resource and represents a promising treatment approach to low back pain. This clinical trial will evaluate an innovative model of an emergency department "embedded" physical therapist to treat patients with chronic low back pain, with a focus on improving patient functioning and reducing opioid use.

Low Back Pain

Northwestern University128 participantsStarted Jan 2022

Chicago, Illinois, United States

RECRUITINGPhase 12.2 miles

Study of JANX008 in Subjects With Advanced or Metastatic Solid Tumor Malignancies

NCT05783622

This study is a first-in-human (FIH), Phase 1/1b, open-label, multicenter dose escalation and dose expansion study to assess the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), and preliminary anti-tumor activity of JANX008 in adult subjects with advanced or metastatic carcinoma expressing EGFR.

Non-Small Cell Lung CancerRenal Cell CarcinomaSquamous Cell Carcinoma of the Head and Neck+4 more

Janux Therapeutics130 participantsStarted Apr 2023

Duarte, California, United States • Sacramento, California, United States • San Diego, California, United States +15 more locations

ED Physical Therapy for Chronic Low Back Pain

Study of JANX008 in Subjects With Advanced or Metastatic Solid Tumor Malignancies

Find Trials by Condition in Chicago

ED Physical Therapy for Acute Low Back Pain

I-131-1095 Radioligand Plus Enzalutamide vs Enzalutamide for mCRPC That Progressed During Abiraterone (ARROW).

Study to Compare Bictegravir/Lenacapavir Versus Current Therapy in People With HIV-1 Who Are Successfully Treated With a Complicated Regimen

Open-Label Safety Study of Acoramidis (AG10) in Symptomatic ATTR Participants

A Study to Confirm Safety and Efficacy of Lecanemab in Participants With Early Alzheimer's Disease

Prolonged Air Leak (PAL) Autologous Blood Patch Intervention Trial

The Periviable GOALS Decision Support Tool

Study of Sitravatinib With or Without Other Anticancer Therapies Receiving Clinical Benefit From Parent Study

Multi-Center Clean Air Randomized Controlled Trial in COPD

A Study of Inhaled AZD8630 in Adolescents With Asthma

Safety and Efficacy of Nyxol With Pilocarpine Eye Drops in Subjects With Presbyopia

RNA Disruption Assay (RDA)-Breast Cancer Response Evaluation for Individualized Therapy

A Study of TLN-254 in Participants With Relapsed or Refractory T-cell Lymphoma

Intent of Surgery for IPMN

Study to Investigate the Safety and Tolerability of Odronextamab in Patients With CD20+ B-Cell Malignancies

A Clinical Trial to Evaluate the Safety and Immunogenicity of BG505 MD39.3, BG505 MD39.3 gp151, and BG505 MD39.3 gp151 CD4KO HIV Trimer mRNA Vaccines in Healthy, HIV-uninfected Adult Participants

A Randomized Phase II Study Of Bruton Tyrosine Kinase Inhibitor With Or Without Venetoclax In Veterans With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint Inhibitor Naïve Participants With Advanced Or Metastatic Merkel Cell Carcinoma